Disease-Inspired Design of Biomimetic Tannic Acid-Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis.

MLA

Elhassan, Eman, et al. “Disease-Inspired Design of Biomimetic Tannic Acid-Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis.” Molecular Pharmaceutics, vol. 21, no. 10, Oct. 2024, pp. 4924–46. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.4c00048.

APA

Elhassan, E., Omolo, C. A., Gafar, M. A., Kiruri, L. W., Ibrahim, U. H., Ismail, E. A., Devnarain, N., & Govender, T. (2024). Disease-Inspired Design of Biomimetic Tannic Acid-Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis. Molecular Pharmaceutics, 21(10), 4924–4946. https://doi.org/10.1021/acs.molpharmaceut.4c00048

Chicago

Elhassan, Eman, Calvin A Omolo, Mohammed Ali Gafar, Lucy W Kiruri, Usri H Ibrahim, Eman A Ismail, Nikita Devnarain, and Thirumala Govender. 2024. “Disease-Inspired Design of Biomimetic Tannic Acid-Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis.” Molecular Pharmaceutics 21 (10): 4924–46. doi:10.1021/acs.molpharmaceut.4c00048.